Fidelity Small Cap Growth Index Fund (FECGX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
29.90
+0.54 (1.84%)
Nov 22, 2024, 5:16 PM EST
38.94% (1Y)
| Fund Assets | 750.19M |
| Expense Ratio | 0.05% |
| Min. Investment | $0.00 |
| Turnover | 48.00% |
| Dividend (ttm) | 0.31 |
| Dividend Yield | 1.06% |
| Dividend Growth | 42.99% |
| Payout Frequency | Semi-Annual |
| Ex-Dividend Date | Aug 9, 2024 |
| Previous Close | 29.36 |
| YTD Return | 21.48% |
| 1-Year Return | 38.12% |
| 5-Year Return | 55.67% |
| 52-Week Low | 21.64 |
| 52-Week High | 30.22 |
| Beta (5Y) | 1.13 |
| Holdings | 1125 |
| Inception Date | Jul 11, 2019 |
About FECGX
The fund normally invests at least 80% of assets in securities included in the Russell 2000® Growth Index, which is a market capitalization-weighted index designed to measure the performance of the small-cap growth segment of the U.S. equity market.
Fund Family Fidelity
Category Small Growth
Performance Rating Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol FECGX
Index Russell 2000 Growth TR
Performance
FECGX had a total return of 38.12% in the past year. Since the fund's inception, the average annual return has been 8.90%, including dividends.
Top 10 Holdings
6.95% of assets| Name | Symbol | Weight |
|---|---|---|
| FTAI Aviation Ltd. | FTAI | 0.96% |
| Insmed Incorporated | INSM | 0.89% |
| Sprouts Farmers Market, Inc. | SFM | 0.79% |
| Fabrinet | FN | 0.67% |
| Vaxcyte, Inc. | PCVX | 0.66% |
| The Ensign Group, Inc. | ENSG | 0.63% |
| Halozyme Therapeutics, Inc. | HALO | 0.60% |
| Applied Industrial Technologies, Inc. | AIT | 0.59% |
| Fluor Corporation | FLR | 0.59% |
| Mueller Industries, Inc. | MLI | 0.57% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Aug 9, 2024 | $0.200 | Aug 12, 2024 |
| Dec 15, 2023 | $0.106 | Dec 18, 2023 |
| Aug 11, 2023 | $0.092 | Aug 14, 2023 |
| Dec 16, 2022 | $0.122 | Dec 19, 2022 |
| Aug 5, 2022 | $0.043 | Aug 8, 2022 |
| Dec 17, 2021 | $0.194 | Dec 20, 2021 |